Benitec Biopharma’s (BNTC) Buy Rating Reiterated at HC Wainwright
Benitec Biopharma (NASDAQ:BNTC – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $28.00 price target on the biotechnology company’s stock. HC Wainwright’s price target indicates a potential upside of 90.87% from the stock’s previous close. A […]
Benitec Biopharma (NASDAQ:BNTC – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in a research note issued on Monday,Benzinga reports. They presently have a $28.00 price target on the biotechnology company’s stock. HC Wainwright’s price target indicates a potential upside of 90.87% from the stock’s previous close. A […]
